iCardiac Technologies

iCardiac Technologies Inc., a Rochester, N.Y.-based commercializer of cardiac safety technologies developed at the University of Rochester Medical Center, has raised an undisclosed amount of private equity funding from Pfizer Inc., as part of a larger strategic agreement. iCardiac raised $4 million in Series A funding late last year from Advantage Capital Partners and Stonehenge Capital. www.icardiac.com www.pfizer.com